Frontlight ResearchEarly access
Acute myeloid leukaemia trials in France
16 of 87 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleCharacterization of CD180 Protein Expression in Myeloid Hematological Malignancies by Flow Cytometry
- Where
- Strasbourg
- Age
- 1 year and over
- People
- 50
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07895901 - No phaseTaking peopleRegistry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
- Where
- Rouen
- Age
- 18 years and over
- People
- 6,990
- Run by
- Groupe Francophone des Myelodysplasies
See details and how to joinNCT06956755 - No phaseTaking peopleBiological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
- Where
- Nantes
- Age
- 18 years to 99 years
- People
- 60
- Run by
- Nantes University Hospital
See details and how to joinNCT06439199 - No phaseNot yet taking people in FranceStudy of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
- Where
- Nantes
- Age
- 18 years and over
- People
- 55
- Run by
- Nantes University Hospital
See details and how to joinNCT07249476 - No phaseTaking peopleCreation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital
- Where
- Nantes
- Age
- 18 years and over
- People
- 1,000
- Run by
- Nantes University Hospital
See details and how to joinNCT06681363 - No phaseTaking peopleEvaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
- Where
- Angers
- Age
- 18 years and over
- People
- 120
- Run by
- University Hospital, Angers
See details and how to joinNCT07147621 - No phaseTaking peopleOBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia
- Where
- Amiens, Angers, Bayonne, Besançon, Clermont-Ferrand, Créteil, Dunkirk, Grenoble, Le Mans, Lyon, Marseille, Meaux, Montpellier, Mulhouse, Nantes, Nice, Orléans, Paris, Pessac, Strasbourg, Toulouse
- Age
- 18 years and over
- People
- 250
- Run by
- French Innovative Leukemia Organisation
See details and how to joinNCT06377579 - No phaseTaking peopleProspective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
- Where
- Amiens, Argenteuil, Bobigny, Caen, Clamart, Corbeil-Essonnes, Créteil, Dijon, Dunkirk, Le Chesnay, Lens, Lille, Limoges, Marseille, Meaux, Nice, Paris, Pierre-Bénite, Pontoise, Roubaix, Rouen, Saint-Cloud, Saint-Quentin, Valenciennes, Villejuif
- Age
- 18 years and over
- People
- 5,000
- Run by
- Acute Leukemia French Association
See details and how to joinNCT04777916 - No phaseNot yet taking people in FranceStudy of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine Hospital
- Where
- Paris
- Age
- 18 years and over
- People
- 750
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05558943 - No phaseTaking peopleEpidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction Therapy
- Where
- Angers, Annecy, Avignon, Bayonne, Besançon, Brest, Clermont-Ferrand, Colmar, Grenoble, Marseille, Metz, Montpellier, Mulhouse, Nantes, Nîmes, Orléans, Paris, Perpignan, Pessac, Poitiers, Reims, Rennes, Saint-Priest-en-Jarez, Strasbourg, Toulouse, Tours, Vandœuvre-lès-Nancy
- Age
- 60 years and over
- People
- 1,000
- Run by
- French Innovative Leukemia Organisation
See details and how to joinNCT06891144 - No phaseTaking peopleCharacterization of the Mechanisms of Resistance to Azacitidine
- Where
- Antibes, Nice
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT01210274 - No phaseTaking peopleRelation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX)
- Where
- Caen
- Age
- 60 years to 90 years
- People
- 100
- Run by
- University Hospital, Caen
See details and how to joinNCT06045819 - No phaseTaking peopleAcute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
- Where
- Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, La Réunion, Lille, Limoges, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg, Toulouse, Tours
- Age
- Up to 25 years
- People
- 500
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05772559 - No phaseTaking peopleThe Patient Cohort of the National Center for Precision Medicine in Leukemia
- Where
- Bobigny, Paris
- People
- 3,000
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05326919 - No phaseTaking peopleDynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia
- Where
- Paris
- Age
- 18 years to 100 years
- People
- 120
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06225128 - No phaseNot yet taking people in FranceRole of BMP Pathway in MDS Progression
- Where
- Lyon
- Age
- 20 years and over
- People
- 60
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT06175923